Elevance Health, Inc. - Common Stock (ELV)

Historical Holders from Q1 2014 to Q1 2025

Symbol
ELV on NYSE
CUSIP
036752103
Type / Class
Equity / Common Stock
Shares outstanding
227M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
205M
Holdings value
$75.6B
% of all portfolios
0.06%
Grand Portfolio weight change
+0.002%
Number of holders
1560
Number of buys
558
Number of sells
-994
Average Value change %
+0%
Average buys %
+0.017%
Average sells %
-0.017%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elevance Health, Inc. - Common Stock (ELV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $7.49B 17.7M BlackRock, Inc. Mar 31, 2025

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 2.08M $905M -$25.3M $434.96 256
2024 Q4 205M $75.6B +$848M $368.90 1,560
2024 Q3 201M $104B -$3.94B $520.00 1,668
2024 Q2 207M $112B +$2.69B $541.86 1,686
2024 Q1 203M $105B -$2.5B $518.54 1,647
2023 Q4 208M $97.9B +$1.12B $471.56 1,621
2023 Q3 205M $89.3B -$735M $435.42 1,495
2023 Q2 204M $90.8B -$2.61B $444.29 1,490
2023 Q1 209M $96.3B -$1.14B $459.81 1,483
2022 Q4 209M $107B -$237M $512.97 1,512
2022 Q3 213M $96.7B -$139M $454.24 1,402
2022 Q2 213M $103B -$37M $482.58 1,410
2022 Q1 214M $105B +$449M $491.22 1,388
2021 Q4 214M $98.9B -$678M $463.54 1,346
2021 Q3 215M $80.1B -$363M $372.80 1,194
2021 Q2 216M $82.4B -$232M $381.80 1,207
2021 Q1 210M $75.3B +$617M $358.95 1,184
2020 Q4 204M $65.4B -$1.3B $321.09 1,141
2020 Q3 222M $59.5B -$837M $268.59 1,061
2020 Q2 216M $56.8B +$598M $262.98 1,076
2020 Q1 219M $49.8B -$353M $227.04 1,010
2019 Q4 222M $67.1B -$902M $302.03 1,082
2019 Q3 223M $53.5B -$531M $240.10 989
2019 Q2 228M $64.1B +$2.25B $282.21 1,005
2019 Q1 226M $64.9B -$546M $286.98 1,050
2018 Q4 228M $59.9B +$655M $262.63 972
2018 Q3 225M $61.5B -$53.8M $274.05 927
2018 Q2 228M $54.2B +$1.05B $238.03 908
2018 Q1 226M $49.6B +$122M $219.70 907
2017 Q4 226M $50.8B -$173M $225.01 895
2017 Q3 227M $43B -$966M $189.88 832
2017 Q2 235M $44.2B -$695M $188.13 838
2017 Q1 236M $39.1B +$4.03B $165.38 778
2016 Q4 236M $33.9B +$285M $143.77 765
2016 Q3 233M $29.2B -$467M $125.31 715
2016 Q2 237M $31.2B +$195M $131.34 740
2016 Q1 236M $32.7B -$91.8M $138.99 754
2015 Q4 236M $33B +$260M $139.44 749
2015 Q3 234M $32.7B +$1.12B $140.00 748
2015 Q2 224M $36.8B -$934M $164.14 766
2015 Q1 233M $35.9B -$122M $154.41 737
2014 Q4 235M $29.5B +$29.3B $125.67 694
2014 Q3 60.8K $7.28M $0 $119.61 1
2014 Q2 60.8K $6.54M +$616K $107.59 1
2014 Q1 55.1K $5.48M +$2.38M $99.54 1